Sawtooth Solutions, LLC United Therapeutics Corp Transaction History

Sawtooth Solutions, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 19, 2022	SELL	$174.81 - $241.14 $263,263 - $363,156	-1,506 Closed	0 $0
Q1 2022 May 20, 2022	BUY	$166.16 - $213.96 $250,236 - $322,223	1,506 New	1,506 $270,000
Q4 2021 Feb 11, 2022	SELL	$184.32 - $216.08 $300,441 - $352,210	-1,630 Closed	0 $0
Q3 2021 Nov 09, 2021	BUY	$179.86 - $214.88 $11,870 - $14,182	66 Added 4.22%	1,630 $301,000
Q2 2021 Sep 01, 2021	SELL	$170.47 - $211.93 $18,069 - $22,464	-106 Reduced 6.35%	1,564 $281,000
Q1 2021 May 13, 2021	SELL	$153.94 - $174.85 $18,626 - $21,156	-121 Reduced 6.76%	1,670 $279,000
Q4 2020 Feb 09, 2021	BUY	$101.87 - $151.79 $182,449 - $271,855	1,791 New	1,791 $272,000

677

42.2M

194K

295K

Ticker UTHR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,516,300
Market Cap $16.9B
Description
United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...

Get notified when there are updates to the investment portfolio of Sawtooth Solutions, LLC, based on Form 13F filings with the SEC.

Stay updated on Sawtooth Solutions, LLC with notifications on news.